Tirzepatide (Mounjaro) A cutting-edge GLP-1 medication with even greater weight loss effects by enhancing insulin sensitivity and reducing hunger
Seven additional phase 3 readouts are expected throughout this year, covering a range of conditions including type 2 diabetes, obstructive sleep apnea, chronic low back pain, cardiovascular outcomes, and metabolic dysfunction-associated steatotic liver disease
PSP : At what stage in a patients weight loss journey do you recommend starting Sofwave treatments to minimize skin issues
Im able to voice my concerns if needed and ask questions of Rae Rx
Check Your Labs : Fatigue can be worsened by low iron, B12, or thyroid issues
[DOI] [PubMed] [Google Scholar] 194.Rosenstock J, Fonseca VA, Gross JL, Ratner RE, Ahren B, Chow FC, Yang F, Miller D, Johnson SL, Stewart MW